Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial
- PMID: 27456494
- PMCID: PMC4960839
- DOI: 10.1186/s13063-016-1486-y
Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial
Abstract
Background: The gut microbiome is increasingly recognized as a contributor to disease states. Patients with type 1 diabetes (DM1) have distinct gut microbiota in comparison to non-diabetic individuals, and it has been linked to changes in intestinal permeability, inflammation and insulin resistance. Prebiotics are non-digestible carbohydrates that alter gut microbiota and could potentially improve glycemic control in children with DM1. This pilot study aims to determine the feasibility of a 12-week dietary intervention with prebiotics in children with DM1.
Methods/design: This pilot study is a single-centre, randomized, double-blind, placebo-controlled trial in children aged 8 to 17 years with DM1 for at least one year. Participants will be randomized to receive either placebo (maltodextrin 3.3 g orally/day) or prebiotics (oligofructose-enriched inulin 8 g orally/day; Synergy1, Beneo, Mannheim, Germany). Measures to be assessed at baseline, 3 months and 6 months include: anthropometric measures, insulin doses/regimens, frequency of diabetic ketoacidosis, frequency of severe hypoglycemia, average number of episodes of hypoglycemia per week, serum C-peptide, HbA1c, serum inflammatory markers (IL-6, IFN-gamma, TNF-alpha, and IL-10), GLP-1 and GLP-2, intestinal permeability using urine assessment after ingestion of lactulose, mannitol and 3-O-methylglucose, and stool sample collection for gut microbiota profiling.
Discussion: This is a novel pilot study designed to test feasibility for a fully powered study. We hypothesize that consumption of prebiotics will alter gut microbiota and intestinal permeability, leading to improved glycemic control. Prebiotics are a potentially novel, inexpensive, low-risk treatment addition for DM1 that may improve glycemic control by changes in gut microbiota, gut permeability and inflammation.
Trial registration: ClinicalTrials.gov: NCT02442544 . Registered on 10 March 2015.
Keywords: Child; Gut microbiota; Intestinal permeability; Prebiotics; Type 1 diabetes.
Similar articles
-
Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children With Type 1 Diabetes.J Clin Endocrinol Metab. 2019 Oct 1;104(10):4427-4440. doi: 10.1210/jc.2019-00481. J Clin Endocrinol Metab. 2019. PMID: 31188437 Clinical Trial.
-
The effect of oligofructose-enriched inulin supplementation on gut microbiota, nutritional status and gastrointestinal symptoms in paediatric coeliac disease patients on a gluten-free diet: study protocol for a pilot randomized controlled trial.Nutr J. 2017 Aug 22;16(1):47. doi: 10.1186/s12937-017-0268-z. Nutr J. 2017. PMID: 28830428 Free PMC article. Clinical Trial.
-
Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity.Gastroenterology. 2017 Sep;153(3):711-722. doi: 10.1053/j.gastro.2017.05.055. Epub 2017 Jun 5. Gastroenterology. 2017. PMID: 28596023 Clinical Trial.
-
Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:64-68. doi: 10.1111/jgh.13700. J Gastroenterol Hepatol. 2017. PMID: 28244671 Review.
-
Mechanisms of Action of Prebiotics and Their Effects on Gastro-Intestinal Disorders in Adults.Nutrients. 2020 Apr 9;12(4):1037. doi: 10.3390/nu12041037. Nutrients. 2020. PMID: 32283802 Free PMC article. Review.
Cited by
-
Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages.Front Immunol. 2018 Oct 9;9:2240. doi: 10.3389/fimmu.2018.02240. eCollection 2018. Front Immunol. 2018. PMID: 30356736 Free PMC article. Review.
-
Holistic perspective of the role of gut microbes in diabetes mellitus and its management.World J Diabetes. 2021 Sep 15;12(9):1463-1478. doi: 10.4239/wjd.v12.i9.1463. World J Diabetes. 2021. PMID: 34630900 Free PMC article. Review.
-
Gut Microbiome as Potential Therapeutics in Multiple Sclerosis.Curr Treat Options Neurol. 2021 Nov;23(11):37. doi: 10.1007/s11940-021-00693-1. Epub 2021 Oct 29. Curr Treat Options Neurol. 2021. PMID: 39877812 Free PMC article.
-
Maternal Inulin Supplementation Alters Hepatic DNA Methylation Profile and Improves Glucose Metabolism in Offspring Mice.Front Physiol. 2020 Feb 7;11:70. doi: 10.3389/fphys.2020.00070. eCollection 2020. Front Physiol. 2020. PMID: 32116778 Free PMC article.
-
Polysaccharide A-Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal Bacteroides fragilis in Type 1 Diabetes.Diabetes. 2019 Oct;68(10):1975-1989. doi: 10.2337/db19-0211. Epub 2019 Jul 16. Diabetes. 2019. PMID: 31311801 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical